Elanco’s $1.6 billion IPO looks too pricey, and here’s why
September 19, 2018 at 16:19 PM EDT
Traditional metrics obscure an expensive valuation for this Eli Lilly spinoff.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|